Evolving chemotherapeutics

David Ranson to join Ausbiotech’s Asian Investment Series in March 2017

David Ranson will be presenting the Deflexifol opportunity to potential investors in Singapore, Hong Kong and Shanghai as part of AusBiotech’s Asian Investment Series, March 21 – 28, 2017. See http://ausbiotechinvestment.com.au/ for more details.